Weijia Xu
- Nephrology top 2%
- Chronic Kidney Disease and Diabetes 9
- Acute Kidney Injury Research 7
-
- Trauma, Hemostasis, Coagulopathy, Resuscitation 1
-
- Cardiac, Anesthesia and Surgical Outcomes 1
-
- Renal cell carcinoma treatment 1
- Kidney Stones and Urolithiasis Treatments 1
-
- Vehicle emissions and performance 1
-
- Advanced Decision-Making Techniques 1
- Journals
- PLoS ONE (2 papers)Biochemical and Biophysical Research Communications (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)
- Partner nations
- China
In The Last Decade
Weijia Xu
13 papers receiving 426 citations
Peers
Comparison fields: 5 of 83
- Nephrology 257
- Critical Care and Intensive Care Medicine 33
- Complementary and alternative medicine 34
- Transplantation 8
- Clinical Biochemistry 19
Countries citing papers authored by Weijia Xu
This map shows the geographic impact of Weijia Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weijia Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weijia Xu more than expected).
Fields of papers citing papers by Weijia Xu
This network shows the impact of papers produced by Weijia Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weijia Xu. The network helps show where Weijia Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Weijia Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 21 | |
| 2 | 2021 | 5 | |
| 3 | 2019 | 1 | |
| 4 | 2017 | 54 | |
| 5 | 2015 | 42 | |
| 6 | 2014 | 68 | |
| 7 | 2014 | 31 | |
| 8 | 2014 | 26 | |
| 9 | 2014 | 150 | |
| 10 | 2014 | 3 | |
| 11 | 2013 | 30 | |
| 12 | Clinical Study of Astragalus Injection on Acute-on-chronic Kidney Injury | 2012 | 1 |
| 13 | 2012 | 4 |
About Weijia Xu
Weijia Xu is a scholar working on Nephrology, Critical Care and Intensive Care Medicine and Complementary and alternative medicine, having authored 13 papers that have together received 436 indexed citations. Recurring topics across this work include Chronic Kidney Disease and Diabetes (9 papers), Acute Kidney Injury Research (7 papers), Cardiac, Anesthesia and Surgical Outcomes (1 paper), Renal cell carcinoma treatment (1 paper), Vehicle emissions and performance (1 paper), Trauma, Hemostasis, Coagulopathy, Resuscitation (1 paper), Advanced Decision-Making Techniques (1 paper) and Kidney Stones and Urolithiasis Treatments (1 paper). The work is most often cited by research in Nephrology (257 citations), Critical Care and Intensive Care Medicine (33 citations) and Complementary and alternative medicine (34 citations). Weijia Xu has collaborated with scholars based in China. Frequent co-authors include Shan Mou, Xinghua Shao, Zhaohui Ni, Lei Tian, Yuanyuan Xie, Chaojun Qi, Zhaohui Ni, Chunlin Wang, Zhen Zhang and Xiajing Che. Their work appears in journals such as PLoS ONE, Biochemical and Biophysical Research Communications and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.